Nachum Shamir - 03 Jun 2026 Form 4 Insider Report for MediWound Ltd. (MDWD)

Reporting relationship
Director
Issuer ticker
MDWD
Reported as of
03 Jun 2026
Net transaction value
+$83,996
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2026, 16:05:18 UTC
Prior SEC filing
18 Mar 2026
Next SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Yaron Meyer, attorney-in-fact

Key filing fact

Nachum Shamir filed Form 4 for MediWound Ltd. (MDWD) on 04 Jun 2026.

Key facts

  • This page summarizes Nachum Shamir's Form 4 filing for MediWound Ltd. (MDWD).
  • 2 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: +$83,996.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622164 Primary reporting owner

SHAMIR NACHUM

Relationship
Director
Address
C/O MEDIWOUND LTD., 42 HAYARKON STREET, YAVNE, ISRAEL
Signature
/s/ Yaron Meyer, attorney-in-fact
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDWD transaction

Ordinary Shares

Purchase

Transaction value
$2,446
Shares
+175
Change %
+0.35%
Price
$13.98
Shares after
49,990
Date
03 Jun 2026
Ownership
Direct
MDWD transaction

Ordinary Shares

Purchase

Transaction value
$81,550
Shares
+5,825
Change %
+12%
Price
$14.00
Shares after
55,815
Date
03 Jun 2026
Ownership
Direct
MDWD holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,200
Date
03 Jun 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDWD holding Derivative

Series A Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,336
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,336
Exercise price
$13.48
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,571
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
28,571
Exercise price
$12.50
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,800
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
11,800
Exercise price
$11.88
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,570
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
12,570
Exercise price
$12.73
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,200
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
9,200
Exercise price
$18.54
Footnotes
F2
MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
03 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,000
Exercise price
$17.60
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

Footnote F2

There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F3

The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .